Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples